Search results for

NPR's Michel Martin speaks with infectious disease epidemiologist and science communicator Jessica Malaty Rivera about the CDC's messaging and rebuilding trust with the public.

DoubleTake magazine, an award-winning literature and photography journal, is on a self-imposed hiatus. The quarterly publication has struggled financially during its eight-year run, and is now looking for backing. Founding editor Dr. Robert Coles speaks with NPR's Steve Inskeep.

BookCrossing.com links together people who share an interest in sharing books -- by leaving them in public places for others to find, and then tracking the results online. For Weekend Edition Saturday, NPR's Neda Ulaby explains how it all works, and looks at another program that has authors stealthily "stocking" bookstores with their own work.

A new poll from the Pew Center for the People and the Press finds that public support for the war remains steadfast. About 70 percent of Americans continue to back the decision to go to war, and that's the case in a Tampa suburb. NPR's David Molpus reports that the mood in military communities like Brandon, Fla., holds steady. At the Catfish Country restaurant most patrons and staff say they're "faithful on the home front."

Casi un año ha pasado desde que la iniciativa Nuestra Casa Saludable de Kentucky (Our Healthy Kentucky Home) empezó.

Edwards made the announcement after the House Ethics Committee recommended he be censured over "persistent unprofessional and inappropriate conduct towards two young female staffers."

Tom Hiddleston stars in the new adaptation of Stephen King's novella — which is somehow a very sweet film about the inevitable approach of death.

Chuck Berry, one of the founders of rock and roll, died Saturday night at age 90. Almost immediately, the tributes started rolling in from some of the most famous names in music.

Many Iowans cannot remember a time when Republican Sen. Chuck Grassley did not represent them in Washington. But as he seeks an eighth term, he faces his toughest race yet.

Mike Flanagan's new film, a maudlin mystery about a man dying of cancer, feels hobbled by its extreme faithfulness to the Stephen King novella on which its based.